Invention Grant
- Patent Title: Methods of using compositions comprising variants and fusions of FGF 19 polypeptides for treating diabetes
-
Application No.: US15950050Application Date: 2018-04-10
-
Publication No.: US10758590B2Publication Date: 2020-09-01
- Inventor: Lei Ling , Darrin Anthony Lindhout
- Applicant: NGM Biopharmaceuticals, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: NGM Biopharmaceuticals, Inc.
- Current Assignee: NGM Biopharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Jones Day
- Main IPC: A61K38/18
- IPC: A61K38/18 ; C07K14/50 ; A61K45/06 ; G01N33/66
Abstract:
The invention relates to methods of using variants and fusions of fibroblast growth factor 19 (FGF19) for treating diabetes.
Public/Granted literature
- US20180362605A1 Compositions and Methods for Treatment of Metabolic Disorders and Diseases Public/Granted day:2018-12-20
Information query
IPC分类:
